Archive | June, 2011

Trends From BIO International Conference: Biotech Sector Performance YTD,MTD

The 2011 Bio Meeting was well attended surpassing last year’s number around 15,000. International participation continues to grow with 37% of attendees outside of the U.S. Virtually every country that has industry and universities is looking at biotech development (BIO will release official data this evening.) The overall view of the biotechnology sector was optimistic […]

Continue Reading 0

BIO International Convention This Week June 27-30; News on AMGN,GILD

We will be attending the BIO Meeting in Washington DC and will not be posting as usual. Note that there were two news items over the weekend on our portfolio stocks: A positive article on Gilead (GILD) in Barron’s. Gilead Sciences Shares Could Rally – Barrons.com Another article in Barron’s which was also covered on […]

Continue Reading 0

Wild Day on Wall Street: Did the RoboTraders Take Over?

Techs and Biotechs Turn Around Its up- its down- its way down -its coming back.At the end of the day NASDAQ recovered up 0.66% after being down more than 1.4%, the Dow was  down 0.49% and the S&P down o.28%. Crosscurrents were too numerous to cover: plunge in oil from emergency release from strategic reserves, […]

Continue Reading 0

MicroCaps Revisited: CONX, ICCC, IVD

Last December we reviewed three low market cap diagnostic stocks that had product revenue, deal or news potential and value. All are up from our last review and Immucell(ICCC $6.97) has appreciated 100% and still has a market cap of only $20M.Immucell is focused in the beef and dairy industries with a diagnostic test for […]

Continue Reading 0

Second Big Rally Day Led by Materials, Technology and Energy: Healthcare Stocks Lag

The market touched the March lows last Friday , down for the year, and buyers swarmed in.Biotechs were strong yesterday buffering tech weakness and today the baton was passed to several sectors with a broad rally especially with NASDAQ up 2.23%. The NASDAQ-100 qqq  was up 2.15%. Leaders were tech and internet stocks the opposite of […]

Continue Reading 0

Biotech Stocks Lead NASDAQ-100 Rally:BIIB,CELG,GILD

NASDAQ stocks rallied today just off March 2011 QQQ bottoms led by large cap biotech stocks.The NASDAQ 100 is up 0.6% led by Biogen Idec(BIIB) up 4.26%, Celgene (CELG) up 3.27%, and Gilead (GILD) up 1.5%.The rally would be stronger were it not for weak tech stocks such as AAPL down 1.6% and RIMM down […]

Continue Reading 0

Diagnostics and Tools Update:EXAS,GNMK,QGEN, RGDX

Busy Day Today -Overall a Lot of Green Screen The diagnostics and tools sector has seen resilience over the past 30 days as the market corrected 7% or more.Bellwether large cap tools stocks with revenue growth such as ILMN,NEOG, TMO have held up well helped by M&A action and good fundamentals. Smaller cap “story” stocks […]

Continue Reading 0

Flight to Safety with Greek Crisis: Some Biotech Winners-SQNM,REGN

Europe debt woes, riots in Greece and a 3% CPI increase for a 12 month period spooked investors. All sectors sold off today with major indices down: NASDAQ off 1.77%,Dow off 1.5%,S&P off 1.7%. Energy, materials, technology and financials were weakest, and all down YTD. The QQQ was down 1.9% but biotechs were among the […]

Continue Reading 0

Relief Rally Boosts Biotechs: BIIB,EXEL,REGN

The market rallied today with the NASDAQ up 1.48 % and the S&P up 1.26%. The leading sectors today were capital goods , materials and energy. Biotechs overall were up only 0.8% but were much better even though our mid-cap index was up only 0.49%. Within the Rayno Life Science Portfolio big winners were Biogen […]

Continue Reading 0

Post-ASCO Scoreboard Part 2

Following up on the previous post we can review selected small and mid-stocks participating in the ASCO Conference look at performance over 3 months from March 14 to June 13 including a 7% correction in the market overall. Most biotech stocks peaked in Q2 2011. See previous post for  ASCO news releases. The broad based […]

Continue Reading 0